Home > > > Report Detail

Global Immuno Oncology Assays Market Insights, Forecast to 2029

Publisher Name :
Date: 03-Aug-2023
No. of pages: 70
Inquire Before Buying

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).

Market Analysis and Insights: Global Immuno Oncology Assays Market

The global Immuno Oncology Assays market is projected to grow from US$ 4987.1 million in 2023 to US$ 9297.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.9% during the forecast period.

The US & Canada market for Immuno Oncology Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Immuno Oncology Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Immuno Oncology Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Immuno Oncology Assays include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Immuno Oncology Assays market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Immuno Oncology Assays, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immuno Oncology Assays, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immuno Oncology Assays revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Immuno Oncology Assays market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Immuno Oncology Assays revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc.

By Company

- Thermo Fischer Scientific

- Roche Diagnostics

- Agilent Technologies

- Illumina

Segment by Type

- Immunoassay

- Flow Cytometry

- PCR

- Next Generation Sequencing

Segment by Application

- Research

- Clinical Diagnostics

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Immuno Oncology Assays in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immuno Oncology Assays companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immuno Oncology Assays revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Immuno Oncology Assays Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno Oncology Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immunoassay
1.2.3 Flow Cytometry
1.2.4 PCR
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Immuno Oncology Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research
1.3.3 Clinical Diagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno Oncology Assays Market Perspective (2018-2029)
2.2 Global Immuno Oncology Assays Growth Trends by Region
2.2.1 Immuno Oncology Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immuno Oncology Assays Historic Market Size by Region (2018-2023)
2.2.3 Immuno Oncology Assays Forecasted Market Size by Region (2024-2029)
2.3 Immuno Oncology Assays Market Dynamics
2.3.1 Immuno Oncology Assays Industry Trends
2.3.2 Immuno Oncology Assays Market Drivers
2.3.3 Immuno Oncology Assays Market Challenges
2.3.4 Immuno Oncology Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immuno Oncology Assays by Players
3.1.1 Global Immuno Oncology Assays Revenue by Players (2018-2023)
3.1.2 Global Immuno Oncology Assays Revenue Market Share by Players (2018-2023)
3.2 Global Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immuno Oncology Assays, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Immuno Oncology Assays Market Concentration Ratio
3.4.1 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Revenue in 2022
3.5 Global Key Players of Immuno Oncology Assays Head office and Area Served
3.6 Global Key Players of Immuno Oncology Assays, Product and Application
3.7 Global Key Players of Immuno Oncology Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno Oncology Assays Breakdown Data by Type
4.1 Global Immuno Oncology Assays Historic Market Size by Type (2018-2023)
4.2 Global Immuno Oncology Assays Forecasted Market Size by Type (2024-2029)
5 Immuno Oncology Assays Breakdown Data by Application
5.1 Global Immuno Oncology Assays Historic Market Size by Application (2018-2023)
5.2 Global Immuno Oncology Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immuno Oncology Assays Market Size (2018-2029)
6.2 North America Immuno Oncology Assays Market Size by Type
6.2.1 North America Immuno Oncology Assays Market Size by Type (2018-2023)
6.2.2 North America Immuno Oncology Assays Market Size by Type (2024-2029)
6.2.3 North America Immuno Oncology Assays Market Share by Type (2018-2029)
6.3 North America Immuno Oncology Assays Market Size by Application
6.3.1 North America Immuno Oncology Assays Market Size by Application (2018-2023)
6.3.2 North America Immuno Oncology Assays Market Size by Application (2024-2029)
6.3.3 North America Immuno Oncology Assays Market Share by Application (2018-2029)
6.4 North America Immuno Oncology Assays Market Size by Country
6.4.1 North America Immuno Oncology Assays Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immuno Oncology Assays Market Size by Country (2018-2023)
6.4.3 North America Immuno Oncology Assays Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Immuno Oncology Assays Market Size (2018-2029)
7.2 Europe Immuno Oncology Assays Market Size by Type
7.2.1 Europe Immuno Oncology Assays Market Size by Type (2018-2023)
7.2.2 Europe Immuno Oncology Assays Market Size by Type (2024-2029)
7.2.3 Europe Immuno Oncology Assays Market Share by Type (2018-2029)
7.3 Europe Immuno Oncology Assays Market Size by Application
7.3.1 Europe Immuno Oncology Assays Market Size by Application (2018-2023)
7.3.2 Europe Immuno Oncology Assays Market Size by Application (2024-2029)
7.3.3 Europe Immuno Oncology Assays Market Share by Application (2018-2029)
7.4 Europe Immuno Oncology Assays Market Size by Country
7.4.1 Europe Immuno Oncology Assays Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immuno Oncology Assays Market Size by Country (2018-2023)
7.4.3 Europe Immuno Oncology Assays Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immuno Oncology Assays Market Size (2018-2029)
8.2 China Immuno Oncology Assays Market Size by Type
8.2.1 China Immuno Oncology Assays Market Size by Type (2018-2023)
8.2.2 China Immuno Oncology Assays Market Size by Type (2024-2029)
8.2.3 China Immuno Oncology Assays Market Share by Type (2018-2029)
8.3 China Immuno Oncology Assays Market Size by Application
8.3.1 China Immuno Oncology Assays Market Size by Application (2018-2023)
8.3.2 China Immuno Oncology Assays Market Size by Application (2024-2029)
8.3.3 China Immuno Oncology Assays Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Immuno Oncology Assays Market Size (2018-2029)
9.2 Asia Immuno Oncology Assays Market Size by Type
9.2.1 Asia Immuno Oncology Assays Market Size by Type (2018-2023)
9.2.2 Asia Immuno Oncology Assays Market Size by Type (2024-2029)
9.2.3 Asia Immuno Oncology Assays Market Share by Type (2018-2029)
9.3 Asia Immuno Oncology Assays Market Size by Application
9.3.1 Asia Immuno Oncology Assays Market Size by Application (2018-2023)
9.3.2 Asia Immuno Oncology Assays Market Size by Application (2024-2029)
9.3.3 Asia Immuno Oncology Assays Market Share by Application (2018-2029)
9.4 Asia Immuno Oncology Assays Market Size by Region
9.4.1 Asia Immuno Oncology Assays Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Immuno Oncology Assays Market Size by Region (2018-2023)
9.4.3 Asia Immuno Oncology Assays Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Immuno Oncology Assays Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Immuno Oncology Assays Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fischer Scientific
11.1.1 Thermo Fischer Scientific Company Details
11.1.2 Thermo Fischer Scientific Business Overview
11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Introduction
11.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2018-2023)
11.1.5 Thermo Fischer Scientific Recent Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Immuno Oncology Assays Introduction
11.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2018-2023)
11.2.5 Roche Diagnostics Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Immuno Oncology Assays Introduction
11.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2018-2023)
11.3.5 Agilent Technologies Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Immuno Oncology Assays Introduction
11.4.4 Illumina Revenue in Immuno Oncology Assays Business (2018-2023)
11.4.5 Illumina Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immuno Oncology Assays Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Immunoassay
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of PCR
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Immuno Oncology Assays Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Immuno Oncology Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Immuno Oncology Assays Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Immuno Oncology Assays Market Share by Region (2018-2023)
Table 10. Global Immuno Oncology Assays Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Immuno Oncology Assays Market Share by Region (2024-2029)
Table 12. Immuno Oncology Assays Market Trends
Table 13. Immuno Oncology Assays Market Drivers
Table 14. Immuno Oncology Assays Market Challenges
Table 15. Immuno Oncology Assays Market Restraints
Table 16. Global Immuno Oncology Assays Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Immuno Oncology Assays Revenue Share by Players (2018-2023)
Table 18. Global Top Immuno Oncology Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2022)
Table 19. Global Immuno Oncology Assays Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Immuno Oncology Assays Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Immuno Oncology Assays, Headquarters and Area Served
Table 22. Global Key Players of Immuno Oncology Assays, Product and Application
Table 23. Global Key Players of Immuno Oncology Assays, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Immuno Oncology Assays Revenue Market Share by Type (2018-2023)
Table 27. Global Immuno Oncology Assays Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Immuno Oncology Assays Revenue Market Share by Type (2024-2029)
Table 29. Global Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Immuno Oncology Assays Revenue Share by Application (2018-2023)
Table 31. Global Immuno Oncology Assays Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Immuno Oncology Assays Revenue Share by Application (2024-2029)
Table 33. North America Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Immuno Oncology Assays Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Immuno Oncology Assays Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Immuno Oncology Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Immuno Oncology Assays Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Immuno Oncology Assays Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Immuno Oncology Assays Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Immuno Oncology Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Immuno Oncology Assays Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Immuno Oncology Assays Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Immuno Oncology Assays Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Immuno Oncology Assays Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Immuno Oncology Assays Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Immuno Oncology Assays Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Immuno Oncology Assays Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Immuno Oncology Assays Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Immuno Oncology Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size by Country (2024-2029) & (US$ Million)
Table 65. Thermo Fischer Scientific Company Details
Table 66. Thermo Fischer Scientific Business Overview
Table 67. Thermo Fischer Scientific Immuno Oncology Assays Product
Table 68. Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 69. Thermo Fischer Scientific Recent Developments
Table 70. Roche Diagnostics Company Details
Table 71. Roche Diagnostics Business Overview
Table 72. Roche Diagnostics Immuno Oncology Assays Product
Table 73. Roche Diagnostics Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 74. Roche Diagnostics Recent Developments
Table 75. Agilent Technologies Company Details
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies Immuno Oncology Assays Product
Table 78. Agilent Technologies Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 79. Agilent Technologies Recent Developments
Table 80. Illumina Company Details
Table 81. Illumina Business Overview
Table 82. Illumina Immuno Oncology Assays Product
Table 83. Illumina Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 84. Illumina Recent Developments
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno Oncology Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Immuno Oncology Assays Market Share by Type: 2022 VS 2029
Figure 3. Immunoassay Features
Figure 4. Flow Cytometry Features
Figure 5. PCR Features
Figure 6. Next Generation Sequencing Features
Figure 7. Global Immuno Oncology Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Immuno Oncology Assays Market Share by Application: 2022 VS 2029
Figure 9. Research Case Studies
Figure 10. Clinical Diagnostics Case Studies
Figure 11. Immuno Oncology Assays Report Years Considered
Figure 12. Global Immuno Oncology Assays Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Immuno Oncology Assays Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Immuno Oncology Assays Market Share by Region: 2022 VS 2029
Figure 15. Global Immuno Oncology Assays Market Share by Players in 2022
Figure 16. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Immuno Oncology Assays Revenue in 2022
Figure 18. North America Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Immuno Oncology Assays Market Share by Type (2018-2029)
Figure 20. North America Immuno Oncology Assays Market Share by Application (2018-2029)
Figure 21. North America Immuno Oncology Assays Market Share by Country (2018-2029)
Figure 22. United States Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Immuno Oncology Assays Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Immuno Oncology Assays Market Share by Type (2018-2029)
Figure 26. Europe Immuno Oncology Assays Market Share by Application (2018-2029)
Figure 27. Europe Immuno Oncology Assays Market Share by Country (2018-2029)
Figure 28. Germany Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Immuno Oncology Assays Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Immuno Oncology Assays Market Share by Type (2018-2029)
Figure 36. China Immuno Oncology Assays Market Share by Application (2018-2029)
Figure 37. Asia Immuno Oncology Assays Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Immuno Oncology Assays Market Share by Type (2018-2029)
Figure 39. Asia Immuno Oncology Assays Market Share by Application (2018-2029)
Figure 40. Asia Immuno Oncology Assays Market Share by Region (2018-2029)
Figure 41. Japan Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Immuno Oncology Assays Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Immuno Oncology Assays Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Immuno Oncology Assays Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Immuno Oncology Assays Market Share by Country (2018-2029)
Figure 51. Brazil Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Immuno Oncology Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Thermo Fischer Scientific Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 58. Roche Diagnostics Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 59. Agilent Technologies Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 60. Illumina Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs